1. Home
  2. HIT vs PMVP Comparison

HIT vs PMVP Comparison

Compare HIT & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.99

Market Cap

68.8M

Sector

Finance

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.19

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIT
PMVP
Founded
1964
2013
Country
United States
United States
Employees
91
N/A
Industry
Specialty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
76.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HIT
PMVP
Price
$0.99
$1.19
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.25
N/A
AVG Volume (30 Days)
274.6K
380.1K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.00
N/A
Revenue Next Year
$69.63
N/A
P/E Ratio
$52.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$0.85
52 Week High
$4.01
$1.88

Technical Indicators

Market Signals
Indicator
HIT
PMVP
Relative Strength Index (RSI) 35.72 34.36
Support Level N/A $1.09
Resistance Level $1.81 $1.26
Average True Range (ATR) 0.13 0.08
MACD -0.03 -0.02
Stochastic Oscillator 20.37 5.71

Price Performance

Historical Comparison
HIT
PMVP

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: